1 / 4

Intravenous Immunoglobulin Market

During the projected period of 2022u20132030, the global intravenous immunoglobulin market is anticipated to expand at a compound annual growth rate (CAGR) of 7.0%.<br>Intravenous immunoglobulin (IVIG) is a blood product or therapy used to treat a variety of illnesses, such as immune thrombocytopenic purpura, hypogammaglobulinemia, Kawasaki disease, Guillain-Barru00e9 syndrome, primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy, <br><br>Read More Information: https://www.xresearch.biz/shop/intravenous-immunoglobulin-Market

niraj6
Download Presentation

Intravenous Immunoglobulin Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intravenous Immunoglobulin Market Size is anticipated to reach at a CAGR of 7.0% during the forecast period During the projected period of 2022–2030, the global intravenous immunoglobulin market is anticipated to expand at a compound annual growth rate (CAGR) of 7.0%. Intravenous immunoglobulin (IVIG) is a blood product or therapy used to treat a variety of illnesses, such as immune thrombocytopenic purpura, hypogammaglobulinemia, Kawasaki disease, Guillain-Barré syndrome, primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy, some cases of HIV/AIDS and measles, and various other infectious diseases. It can be injected into a vein, a muscle, or beneath the skin, depending on how it is made. IVIg is useful for maintaining the proper level of antibodies in the bodies of people or patients who are unable to manufacture enough antibodies. Download Request for Sample@ https://www.xresearch.biz/request-sample- pages/intravenous-immunoglobulin-Market Growth Drivers: The burgeoning adoption and demand of novel intravenous immunoglobulin’s for the treatment of various diseases, the rising number of hemophiliac patients, improving technologies for the production of immunoglobulin and improved purification techniques,

  2. the rising demand for more effective and adequate treatment measures, and the soaring investments in the healthcare sector worldwide are the main factors driving the growth of this market. Immunodeficiency and autoimmune illnesses, such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, and others, reduce a patient's ability to produce antibodies. Immunoglobulin treatments are increasingly used to treat various disorders due to their expanding prevalence worldwide. In addition, the world's growing ageing population, which is more susceptible to most chronic diseases because of decreased immunity, is encouraging the use of intravenous immunoglobulin (IVIG). Request for Customization Pages @ https://www.xresearch.biz/request-for- customization/intravenous-immunoglobulin-Market During the forecast period, it is anticipated that additional factors, including expanding research and development activities and investments, rising government spending on healthcare, rising IVIG awareness, swiftly developing blood plasma-derived products, and widespread use of IVIG for off-label indications, will further boost the growth of the global intravenous immunoglobulin market. Intravenous Immunoglobulin Market Segmentation: By Type: · IgG · IgA · IgM · IgE · IgD By Application: · Hypogammaglobulinemia · Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) · Immunodeficiency Disease

  3. · Myasthenia Gravis · Multifocal Motor Neuropathy · Idiopathic Thrombocytopenic Purpura (ITP) · Inflammatory Myopathies · Specific Antibody Deficiency · Guillain–Barré Syndrome · Others By Region: · North America · Europe · Asia Pacific · Latin America · Middle East and Africa Key Companies in Intravenous Immunoglobulin Market: · Kedrion Biopharma Inc. · LFB group · Biotest AG · China Biologics Products Inc. · Bayer Healthcare · Baxter international Inc. · CSL Ltd. · Grifols S.A · Octapharma AG

  4. · Takeda Pharmaceutical Company Limited · Bio Products Laboratory Limited · Other Players Read More Information: https://www.xresearch.biz/shop/intravenous- immunoglobulin-Market About Us:- xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling. Contact: Company Name: xResearch Contact Person: James Lin Email: sales@xresearch.biz Phone: +1 718-618-4545

More Related